More Articles
New Drugs and Therapeutics Update: JUXTAPID® (lomitapide) capsules Prepared by Daniel Mak, MD On March 3rd, 2026, the FDA approved and expanded indication for JUXTAPID (lomitapide) capsules for pediatric use in children…
Felicia Cooper, MD I am a third-year pediatric endocrinology fellow at Nemours Children’s Health in Orlando, Florida. I will be staying at my current institution as a pediatric endocrinologist starting…
Jordin Frasch, DNP, APRN, CPNP-PC Jordin Frasch, DNP, APRN, CPNP-PC is a Pediatric Nurse Practitioner at Cedars-Sinai Guerin Children’s in the Department of Pediatric Endocrinology in Los Angeles, California. Jordin…
Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO In 1963, Arnold H. Kadish reported on the use of a “servomechanism for glucose monitoring and control,” the first…
New Drugs and Therapeutics Update: Sogroya® (somapacitan-beco) Injection Prepared by Daniel Mak, MD; Edited by Neha Patel, DO On February 27th, 2026, the FDA approved Sogroya® (somapacitan-beco) for three new…
Depo-Provera® and Increased Risk of Meningioma: FDA-Label Update Written by: Anna Ryabets-Lienhard, DO as part of Drugs and Therapeutics Committee In December 2025, the U.S. Food and Drug Administration (FDA) approved…
Navepegritide (Yuviwel®) for Children with Achondroplasia: New Drugs and Therapeutics Written by Anna Ryabets-Lienhard, DO Edited by Neha Patel, DO and Emily Breidbart, MD On February 27th, 2026, the FDA…
In Memoriam: Delbert A Fisher, MD (August 12, 1928 – March 4, 2026) Del Fisher, MD, one of the 38 founding members of our Society (formerly the Lawson Wilkins Pediatric…
March Historical Tidbit – Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO In March 1922, Banting and Best published a preliminary report on the effect of subcutaneously…
